Skip to main content
Log in

Emerging Theranostic Silver and Gold Nanomaterials to Combat Prostate Cancer: A Systematic Review

  • Review Paper
  • Published:
Journal of Cluster Science Aims and scope Submit manuscript

Abstract

Prostate cancer has emerged as the common malignancy in men and is considered as a global issue. Among different strategies to combat prostate cancer, nanobiotechnology appears as a novel approach for prostate cancer theranostics. The current systematic review discussing the recent development in the prostate anticancer activity of biologically synthesized silver nanoparticles (AgNPs) and gold nanoparticles (AuNPs) through laboratory investigations. The databases including Cochrane, Web of Science, PubMed, Scopus, Science Direct, ProQuest, and Embase were used to identify the records. It was found that most of the studies used herbal extracts for preparation of AgNPs and/or AuNPs. Majority of biosynthesized nanoparticles (NPs) were formed with spherical morphology. Besides, all studies reported the size of NPs less than 100 nm. Moreover, PC-3 prostate cancer cell was the predominant cell line that was evaluated for prostate anticancer activity of NPs. In the present study, we provided valuable information suggesting the significant prostate anticancer potential of biogenic AgNPs and/or AuNPs. However, further, in vivo investigations are required to provide stronger evidence of the efficacy of bio-mediated synthesized AgNPs and/or AuNPs to combat prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. S. Zaidi, J. Gandhi, G. Joshi, N. L. Smith, and S. A. Khan (2019). Prostate Cancer Prostatic Dis.. https://doi.org/10.1038/s41391-018-0085-2.

    Article  PubMed  Google Scholar 

  2. O. Sartor and J. S. de Bono (2018). N. Engl. J. Med. 378, 645.

    CAS  PubMed  Google Scholar 

  3. R. L. Siegel, K. D. Miller, and A. Jemal (2019). CA Cancer J. Clin. 69, 7.

    PubMed  Google Scholar 

  4. American Cancer Society Cancer Facts & Figures 2019 (American Cancer Society, Atlanta, 2019).

    Google Scholar 

  5. J. Ferlay, M. Colombet, I. Soerjomataram, T. Dyba, G. Randi, M. Bettio, A. Gavin, O. Visser, and F. Bray (2018). Eur. J. Cancer 103, 356.

    CAS  PubMed  Google Scholar 

  6. D. Cunningham and Z. You (2015). J. Biol. Methods 2, e17.

    PubMed  PubMed Central  Google Scholar 

  7. J. C. Henegan and G. Sonpavde (2018). Exp. Opin. Biol. Ther. 18, 109.

    CAS  Google Scholar 

  8. V. K. Lakshmanan (2016). Investig. Clin. Urol. 57, 21.

    PubMed  PubMed Central  Google Scholar 

  9. H. Barabadi, M. A. Mahjoub, B. Tajani, A. Ahmadi, Y. Junejo, and M. Saravanan (2019). J. Clust. Sci. 30, 259.

    CAS  Google Scholar 

  10. H. Barabadi (2017). Cell. Mol. Biol. 63, 3.

    PubMed  Google Scholar 

  11. H. Barabadi, F. Kobarfard, and H. Vahidi (2018). Iran J. Pharm. Res. 17, 87.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. H. Barabadi, A. Alizadeh, M. Ovais, A. Ahmadi, Z. K. Shinwari, and M. Saravanan (2018). IET Nanobiotechnol. 12, 377.

    PubMed  Google Scholar 

  13. H. Barabadi, M. Ovais, Z. K. Shinwari, and M. Saravanan (2017). Green Chem. Lett. Rev. 10, 285.

    CAS  Google Scholar 

  14. H. Barabadi, S. Honary, P. Ebrahimi, M. A. Mohammadi, A. Alizadeh, and F. Naghibi (2014). Braz. J. Microbiol. 45, 1493.

    CAS  PubMed  Google Scholar 

  15. H. Barabadi, Z. Alizadeh, M. T. Rahimi, A. Barac, A. E. Maraolo, L. J. Robertson, A. Masjedi, F. Shahrivar, and E. Ahmadpour (2019). Nanomedicine: NBM 18, 221.

    CAS  Google Scholar 

  16. N. Karimi, A. Chardoli, and A. Fattahi (2017). Iran. J. Pharm. Res. 16, 1167.

    PubMed  PubMed Central  Google Scholar 

  17. S. Salari, S. Esmaeilzadeh Bahabadi, A. Samzadeh-Kermani, and F. Yousefzaei (2019). Iran. J. Pharm. Res. 18, 430.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Z. Rezvani Amin, Z. Khashyarmanesh, B. S. Fazly Bazzaz, and Z. Sabeti Noghabi (2019). Iran. J. Pharm. Res. 18, 210.

    PubMed  PubMed Central  Google Scholar 

  19. T. Ramezani, M. Nabiuni, J. Baharara, K. Parivar, and F. Namvar (2019). Iran. J. Pharm. Res. 18, 222.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. M. M. Or Rashid, M. S. Islam, M. A. Haque, M. A. Rahman, M. T. Hossain, and M. A. Hamid (2016). Iran. J. Pharm. Res. 15, 591.

    PubMed  PubMed Central  Google Scholar 

  21. R. Dobrucka (2017). Iran. J. Pharm. Res. 16, 753.

    CAS  Google Scholar 

  22. Q. Abbas, M. Saleem, A. R. Phull, M. Rafiq, M. Hassan, K.-H. Lee, and S.-Y. Seo (2017). Iran. J. Pharm. Res. 16, 760.

    CAS  Google Scholar 

  23. H. Barabadi, B. Tajani, M. Moradi, K. Damavandi Kamali, R. Meena, S. Honary, M. A. Mahjoub, and M. Saravanan (2019). J. Clust. Sci.. https://doi.org/10.1007/s10876-019-01554-3.

    Article  Google Scholar 

  24. P. Boomi, G. P. Poorani, S. Palanisamy, S. Selvam, G. Ramanathan, S. Ravikumar, H. Barabadi, H. G. Prabu, J. Jeyakanthan, and M. Saravanan (2019). J. Clust. Sci. 30, 715.

    CAS  Google Scholar 

  25. K. Rasmussen, H. Rauscher, A. Mech, J. Riego Sintes, D. Gilliland, M. Gonzalez, P. Kearns, K. Moss, M. Visser, M. Groenewold, and E. A. J. Bleeker (2018). Regul. Toxicol. Pharmacol. 92, 8.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. B. D. Chithrani, A. A. Ghazani, and W. C. Chan (2006). Nano Lett. 6, 662.

    CAS  PubMed  Google Scholar 

  27. S. Hauert and S. N. Bhatia (2014). Trends Biotechnol. 32, 448.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. M. S. Bethu, V. R. Netala, L. Domdi, V. Tartte, and V. R. Janapala (2018). Artif. Cells Nanomed. Biotechnol. 46, S104.

    Google Scholar 

  29. M. S. Bethu and J. Venkateswara Rao (2017). Asian J. Pharm. Clin. Res. 10, 65.

    Google Scholar 

  30. A. Parveen and S. Rao (2015). J. Clust. Sci. 26, 775.

    CAS  Google Scholar 

  31. E. B. El Domany, T. M. Essam, A. E. Ahmed, and A. A. Farghali (2018). J. Appl. Pharm. Sci. 8, 119.

    Google Scholar 

  32. K. Kalaiarasi, G. Prasannaraj, S. V. Sahi, and P. Venkatachalam (2015). Turk. J. Biol. 39, 223.

    CAS  Google Scholar 

  33. G. Prasannaraj, S. V. Sahi, S. Ravikumar, and P. Venkatachalam (2016). J. Nanosci. Nanotechnol. 16, 4948.

    CAS  PubMed  Google Scholar 

  34. G. Prasannaraj and P. Venkatachalam (2017). Adv. Nat. Sci. Nanosci. 8, 025001.

    Google Scholar 

  35. K. Rajathi, N. Kannikaparameswari, and S. Suja (2017). Eur. J. Pharm. Sci. 4, 401.

    Google Scholar 

  36. H. Barabadi, S. Honary, M. Ali Mohammadi, E. Ahmadpour, M. T. Rahimi, A. Alizadeh, F. Naghibi, and M. Saravanan (2017). Environ. Sci. Pollut. Res. Int. 24, 5800.

    CAS  PubMed  Google Scholar 

  37. M. J. Firdhouse and P. Lalitha (2013). Cancer Nanotechnol. 4, 137.

    PubMed  PubMed Central  Google Scholar 

  38. Y. He, Z. Du, S. Ma, S. Cheng, S. Jiang, Y. Liu, D. Li, H. Huang, K. Zhang, and X. Zheng (2016). Nanoscale Res. Lett. 11, 300.

    PubMed  PubMed Central  Google Scholar 

  39. Y. Q. He, X. Li, Y. Y. Zheng, Z. Y. Wang, Z. Y. Ma, Q. Yang, B. H. Yao, Y. J. Zhao, and H. Zhang (2018). New J. Chem. 42, 2882.

    CAS  Google Scholar 

  40. J. Raman, G. R. Reddy, H. Lakshmanan, V. Selvaraj, B. Gajendran, R. Nanjian, A. Chinnasamy, and V. Sabaratnam (2015). Process Biochem. 50, 140.

    CAS  Google Scholar 

  41. Y. Q. He, X. Li, J. Wang, Q. Yang, B. H. Yao, Y. J. Zhao, A. M. Zhao, W. X. Sun, and Q. Zhang (2017). Environ. Toxicol. Pharmacol. 56, 56.

    CAS  PubMed  Google Scholar 

  42. R. E. Heravi, S. Zakeri, and P. Nazari (2018). Micro Nano Lett. 13, 1475.

    CAS  Google Scholar 

  43. K. Jadhav, S. Deore, D. Dhamecha, H. R. Rajeshwari, S. Jagwani, S. Jalalpure, and R. Bohara (2018). ACS Biomater. Sci. Eng. 4, 892.

    CAS  Google Scholar 

  44. D. G. Kumar, N. S. Raj, R. Kumar, and K. S. Nagendra (2017). Int. Res. J. Pharm. 8, 109.

    CAS  Google Scholar 

  45. R. I. Priyadharshini, G. Prasannaraj, N. Geetha, and P. Venkatachalam (2014). Appl. Biochem. Biotechnol. 174, 2777.

    CAS  PubMed  Google Scholar 

  46. O. S. Adeyemi and F. A. Sulaiman (2015). J. Biomed. Res. 29, 145.

    PubMed  Google Scholar 

  47. K. M. Ardhendu (2017). Glob. J. Nanomed. 3, 555607.

    Google Scholar 

  48. S. Khalid and R. Hanif (2017). IJASET 5, 59.

    Google Scholar 

  49. M. Naz, N. Nasiri, M. Ikram, M. Nafees, M. Z. Qureshi, S. Ali, and A. Tricoli (2017). Appl. Nanosci. 7, 793.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Hamed Barabadi or Muthupandian Saravanan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barabadi, H., Damavandi Kamali, K., Jazayeri Shoushtari, F. et al. Emerging Theranostic Silver and Gold Nanomaterials to Combat Prostate Cancer: A Systematic Review. J Clust Sci 30, 1375–1382 (2019). https://doi.org/10.1007/s10876-019-01588-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10876-019-01588-7

Keywords

Navigation